New COVID variant ‘likely’ this year: Top French master Kumar Jeetendra | July 23, 2021 The French government’s top advisor on COVID-19 warned Friday that a new variant of the disease would “probably” emerge in the winter months this year. The country is currently battling an unprecedented spike in new cases caused by the more infectious Delta variant, which was first recorded in India. “We will probably have another variant …
Bharat Biotech commits to supply 500 million dosages of Covaxin to Center for vaccination drive Kumar Jeetendra | July 23, 2021 Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme. Speaking at a virtual conference organised by the Confederation of Indian Industry, Suchitra Ella, joint Managing Director of the city-based vaccine maker, said the companys facilities in four …
Prevalence of COVID-19’s Delta variant among samples sequenced over recent weeks surpassed 75%: WHO Kumar Jeetendra | July 22, 2021 The prevalence of the highly-transmissible Delta variant of COVID-19 among specimens sequenced over the past four weeks exceeded 75 percent in many countries worldwide, including India, China, Russia, Israel and the UK, the WHO has said. In the COVID-19 Weekly Epidemiological Update published July 20, the World Health Organisation said that despite efforts to extend …
China says ”shocked” by WHO plan for COVID source: Study Kumar Jeetendra | July 22, 2021 A senior Chinese health official said Thursday he was shocked by the World Health Organisation’s plan for the second phase of a COVID-19 origins study. National Health Commission Vice Minister Zeng Yixin dismissed the lab leak theory as a rumor running counter to common sense. The head of the WHO acknowledged last week that it …
Johnson and Johnson raises figures, estimates $2.5 billion in COVID-19 vaccine deals Kumar Jeetendra | July 21, 2021 Johnson & Johnson on Wednesday raised its overall revenue estimate for the year and forecast $2.5 billion in sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns. Although Johnson & Johnson’s shot was approved in the United …
SMART Breakthrough in Detection of SARS-CoV-2 Variant in Wastewater Kumar Jeetendra | July 21, 2021 Singapore, 21 July 2021 – Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, alongside collaborators from Biobot Analytics, Nanyang Technological University (NTU) and Massachusetts Institute of Technology (MIT), have successfully developed an innovative, open-source molecular detection method that is able …
IISc-incubated vaccine innovation startup Mynvax raises $4.2 million Kumar Jeetendra | July 19, 2021 Mynvax, a vaccine technology startup incubated by the Society for Innovation and Development (SID) at the Indian Institute of Science, on Monday announced that it has signed definitive agreements to raise $4.2 million (Rs 31 crore) in its Series A round of financing led by Accel. The company said in a statement it is developing …
Central amygdala micro circuits assume dynamic part in regulation of dread responses Kumar Jeetendra | July 17, 2021 Because they can be used to treat anxiety disorders, the brain mechanisms that suppress fear reactions have been a focus of much attention. Although we have a good understanding of the brain regions that are activated when fear is experienced, it remains to be largely unknown how fear reactions can be suppressed. Researchers from the …
UK plans biggest flu program with free immunizations for millions Kumar Jeetendra | July 17, 2021 UK’s Health and Social Care Secretary Sajid Javid on Saturday announced that millions of more people will be offered a free flu vaccine this year as part of the British government’s most comprehensive flu vaccination programme in history to help back up the coronavirus fight. From September, the National Health Service (NHS) will offer the …
Bharat Biotech’s partner Ocugen looks for endorsement for Covaxin in Canada Kumar Jeetendra | July 16, 2021 Ocugen Inc., Bharat Biotech’s partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the jab, the US company said in a regulatory filing. The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, …
IISc-Bengaluru’s ‘warm’ COVID vaccine powerful against all significant variants of concern: Study Kumar Jeetendra | July 16, 2021 A heat-tolerant COVID-19 vaccine formulation developed by the Indian Institute of Science (IISc) Bengaluru has proven effective against all current SARS-CoV-2 variants of concern, according to a study in animals. The research, published in the ACS Infectious Diseases journal on Thursday, showed the vaccine formulations by IISc-incubated biotech start-up Mynvax triggered a strong immune response …
China must co-work better with COVID origin test: WHO Kumar Jeetendra | July 15, 2021 China must co-operate better in the probe into the origins of the coronavirus pandemic, the first cases of which were seen in Wuhan in December 2019, the head of World Health Organization said on Thursday. “We hope there will be better co-operation to get to the bottom of what happened,” Tedros Adhanom Ghebreyesus told a …
